Article metrics

Download PDFPDF

Original research
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

 

Online download statistics by month:

Online download statistics by month: July 2020 to September 2024

AbstractFullPdf
Jul 2020597598182
Aug 202023523248
Sep 202010610653
Oct 2020828230
Nov 2020535520
Dec 2020575717
Jan 2021575721
Feb 2021575730
Mar 2021878733
Apr 2021606028
May 2021535334
Jun 2021959543
Jul 2021909033
Aug 202116916919
Sep 2021636325
Oct 2021727252
Nov 2021777734
Dec 2021758037
Jan 2022747926
Feb 2022424235
Mar 202214214638
Apr 2022717422
May 2022707435
Jun 2022687331
Jul 2022505327
Aug 2022687127
Sep 2022757538
Oct 2022808561
Nov 2022868625
Dec 2022474719
Jan 2023747433
Feb 2023828226
Mar 2023929334
Apr 2023495125
May 2023656527
Jun 2023616118
Jul 2023484926
Aug 2023575720
Sep 2023565617
Oct 2023546415
Nov 2023696926
Dec 2023555525
Jan 2024565730
Feb 2024646432
Mar 2024636476
Apr 2024676942
May 2024596046
Jun 2024555646
Jul 2024888943
Aug 2024555530
Sep 2024727541
Total429943601801